Add New
    0
    Add New

    Argonaut Therapeutics

    Argonaut Therapeutics is a spin-out from Oxford University’s Medical Sciences Division focusing on new cancer treatments. The technology is based on original discoveries made in Oxford that characterised abnormal arginine methylation in advanced and metastatic tumours. This established PRMT5 as a drug target and the company generated two distinct series of PRMT5 inhibitors, coupled with proprietary companion diagnostics, which enable a precision medicine approach to treating cancer.

    Description

    SHORT DESCRIPTION:

    Argonaut Therapeutics is a spin-out from Oxford University’s Medical Sciences Division focusing on new cancer treatments. The technology is based on original discoveries made in Oxford that characterised abnormal arginine methylation in advanced and metastatic tumours. This established PRMT5 as a drug target and the company generated two distinct series of PRMT5 inhibitors, coupled with proprietary companion diagnostics, which enable a precision medicine approach to treating cancer.

     

    LONG DESCRIPTION:

    Based in

    Oxford, Oxfordshire

    Get Directions
    Founded in

    2016

    Founding Status

    $ 2.5 Millions - $ 5 Millions

    Follow us
    mood_bad
  • No comments yet.
    • Add a review

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    General Rating

    Products / Services

    Pricing

      You May Also Be Interested In

      error: Content protected